ART

This study was aimed at identifying the CLINICO-EPIDEMOLOGICAL study of underlying HIV–TB coinfection. A retrospective review of patient records was done from the antiretroviral therapy center (ART) at a government hospital in southern India between June 2018 and April 2019. Secondary data of 10155 patients on ART as well as pre-ART were collected between January 2009 and December 2018 and were analyzed. Wilcoxon signed rank tests were used with SPSS version 15.0 The prevalence of HIV-TB coinfection 0.13% among the sample was taken. HIV–TB coinfection was increased in trend of population from 1.41% in 2009 to 45.3% in 2018 until when the data were included in this study. The proportion of HIV infection among those registering at this particular ART center decreased from 18.7% in 2009 to 6.44% in 2018. The prevalence of HIV infection and HIV-TB coinfection higher in males (3.73% & 33.3%) than females (3.20% & 12.05%) respectively among those registering at this particular ART center. The fatality rate of HIV infection was decreased from 23.4% in 2009 to 2.33% in 2018. The CD4 count (200 cells/µl) lower in co-infected patients than HIV infected patients. The increasing trend of HIV–TB cases observed in this population from 1.41% in 2009 to 45.3% in December 2018. Creating grass root level awareness coupled with aggressive case finding in suspected high-risk population may be key in preventing and early detection of the dual infections.

In 2013 world health organization concluded that approximately around 35.0 million people have been infected with HIV and about 1.5 million people have died of AIDS. Most of the people infected with HIV particularly African regions. World health organization continuous to bear the burnt of HIV epidemic in sub Saharan African region like Zimbabwe. This country is experiencing one of the harshest HIV/AIDS epidemics in the world .So according to performance of ART program estimated that percentage of eligible adulates 76.9% and children’s around 46.12 % in 2013. The statistical information about Global economic environment in ARV business has continued to grow in the generic-accessible market. So it is an essential need for quality assured ART’s with proper regulatory control and evolution procedures. In this paper work it involves how will the Anti Retroviral generic drugs filing have been processed based on Medicinal Control Authority of Zimbabwe [MCAZ].